TMCI
TREACE MEDICAL CONCEPTS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$4.49
−0.88%Sep 17, 2026, 21:16 UTC
Treace Medical Concepts announced the presentation of results from three clinical studies — the 5-year ALIGN3D Lapiplasty, MTA3D Adductoplasty and SPRINT SpeedPlate studies — at the American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle, Washington.
Source:Aug 7, 2026, 11:05 UTC
Treace Medical Concepts reported its financial results for the second quarter ended June 30, 2026.
Jun 18, 2026, 11:05 UTC
Treace Medical Concepts completed the first surgical case using its new HyperPlate XM Dynamic Compression Locking Implant System.